COSMOS Pharmaceutical Corporation
CSMYF · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $336,809 | $57,038,000 | $22,765,000 | $39,129,000 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $5,235 | $12,240,000 | $672,000 | $683,000 |
| Inventory | $606,233 | $92,323,000 | $88,059,000 | $93,850,000 |
| Other Curr. Assets | $134,253 | $4,021,000 | $15,367,000 | $16,358,000 |
| Total Curr. Assets | $1,082,530 | $165,622,000 | $126,863,000 | $150,020,000 |
| Property Plant & Equip (Net) | $2,290,189 | $348,162,000 | $320,043,000 | $326,259,000 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $4,555 | $446,000 | $431,000 | $453,000 |
| Long-Term Investments | $29,895 | $0 | $0 | $26,391,000 |
| Tax Assets | $0 | $2,913,000 | $0 | $0 |
| Other NC Assets | $157,580 | $7,608,000 | $26,764,000 | -$16,555,000 |
| Total NC Assets | $2,482,220 | $359,129,000 | $347,238,000 | $336,548,000 |
| Other Assets | $0 | $4,000 | $0 | $3,000 |
| Total Assets | $3,564,750 | $524,755,000 | $474,101,000 | $486,571,000 |
| Liabilities | – | – | – | – |
| Payables | $1,216,837 | $177,125,000 | $156,818,000 | $173,939,000 |
| Short-Term Debt | $37,272 | $7,938,000 | $8,006,000 | $4,331,000 |
| Tax Payable | $0 | $11,651,000 | $0 | $7,874,000 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $214,719 | $23,966,000 | $30,840,000 | $26,689,000 |
| Total Curr. Liab. | $1,468,829 | $220,680,000 | $195,664,000 | $212,833,000 |
| LT Debt | $245,199 | $42,019,000 | $20,523,000 | $21,344,000 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $64,896 | $4,593,000 | $9,092,000 | $8,908,000 |
| Total NC Liab. | $310,096 | $46,612,000 | $29,615,000 | $30,252,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $7,073,000 | $0 | $0 |
| Total Liabilities | $1,778,924 | $267,292,000 | $225,279,000 | $243,085,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $28,406 | $4,178,000 | $4,178,000 | $4,178,000 |
| Retained Earnings | $1,723,601 | $248,309,000 | $239,674,000 | $234,335,000 |
| AOCI | $653 | $0 | $96,000 | $98,000 |
| Other Equity | $33,152 | $4,975,000 | $4,874,000 | $4,874,000 |
| Total Equity | $1,785,812 | $257,462,000 | $248,822,000 | $243,484,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,564,736 | $524,754,000 | $474,101,000 | $486,569,000 |
| Net Debt | -$54,338 | -$7,081,000 | $5,764,000 | -$13,454,000 |